HOME
Leading the way to a cure

Lupus News

Drug Combo Offers Long-Term Benefits in SLE

November 18, 2012
WASHINGTON -- An 18-month treatment with the combination of rituximab and cyclophosphamide (Cytoxan) stopped progression of systemic lupus erythematosus (SLE) for at least 3 years, researchers here.

See full story >


Proteinuria Recovery Heads Off LN Comorbidities

November 12, 2012
WASHINGTON, D.C.—Achieving partial or complete recovery from proteinuria in patients with active lupus nephritis (LN) at one year from disease onset may protect against comorbidities, including...

See full story >


Long-Term Efficacy and Safety Results of Epratuzumab in Lupus Presented at Rheumatology Conference

November 12, 2012
WASHINGTON, Nov. 12, 2012 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the...

See full story >


Lupus Nephritis Patient Genotype May Not Predict MMF Response

November 12, 2012
WASHINGTON, D.C.—The genotypes of patients with lupus nephritis (LN) may not predict response to mycophenolate mofetil (MMF), according to a new study presented at the American College of...

See full story >


The IHeartRadio Music Festival Rocked Las Vegas for the Second Year with the Biggest Concert and Talent in Radio History

September 24, 2012
The 2012 Festival Celebrates The Incredible Success Of The New iHeartRadio Since Its Launch At The Inaugural 2011 Event The Sold Out Festival Also Raised More Than $500K For National Charities,...

See full story >


Items 81 - 85 of 100  Previous11121314151617181920Next

1.5 million

people in the U.S. have Lupus.

90 million

dollars committed to lupus research by the Alliance for Lupus Research.


We're walking across the United States to raise awareness and funds for lupus research.

Can't make it? Join our National Virtual Walk to participate anytime, anywhere.


Show your support by visiting the Alliance for Lupus Research online store. Discover the perfect gift, or prepare for a walk with our selection of apparel and accessories.